Neuphoria Therapeutics Statistics
Total Valuation
NEUP has a market cap or net worth of $8.86 million. The enterprise value is $4.68 million.
Important Dates
The next estimated earnings date is Thursday, May 15, 2025, before market open.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NEUP has 1.76 million shares outstanding. The number of shares has increased by 126.50% in one year.
Current Share Class | 1.76M |
Shares Outstanding | 1.76M |
Shares Change (YoY) | +126.50% |
Shares Change (QoQ) | -99.94% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 14.71% |
Float | 723,231 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 13.36 |
Forward PS | n/a |
PB Ratio | 0.60 |
P/TBV Ratio | 43.29 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 7.06 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.06 |
Quick Ratio | 2.05 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.98% and return on invested capital (ROIC) is -53.32%.
Return on Equity (ROE) | -48.98% |
Return on Assets (ROA) | -41.53% |
Return on Invested Capital (ROIC) | -53.32% |
Return on Capital Employed (ROCE) | -92.53% |
Revenue Per Employee | $27,613 |
Profits Per Employee | -$342,221 |
Employee Count | 24 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -138,311 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 5.16 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 44.03 |
Average Volume (20 Days) | 21,424 |
Short Selling Information
The latest short interest is 35,385, so 2.01% of the outstanding shares have been sold short.
Short Interest | 35,385 |
Short Previous Month | 49,711 |
Short % of Shares Out | 2.01% |
Short % of Float | 4.89% |
Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, NEUP had revenue of $662,715 and -$8.21 million in losses. Loss per share was -$0.00.
Revenue | 662,715 |
Gross Profit | 2.15M |
Operating Income | -14.84M |
Pretax Income | n/a |
Net Income | -8.21M |
EBITDA | -14.39M |
EBIT | -14.84M |
Loss Per Share | -$0.00 |
Full Income Statement Balance Sheet
The company has $4.34 million in cash and $168,310 in debt, giving a net cash position of $4.18 million or $2.38 per share.
Cash & Cash Equivalents | 4.34M |
Total Debt | 168,310 |
Net Cash | 4.18M |
Net Cash Per Share | $2.38 |
Equity (Book Value) | 13.75M |
Book Value Per Share | 8.44 |
Working Capital | 2.26M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -14.10M |
Capital Expenditures | n/a |
Free Cash Flow | -14.10M |
FCF Per Share | -$8.02 |
Full Cash Flow Statement Margins
Gross Margin | 324.11% |
Operating Margin | -2,238.73% |
Pretax Margin | -1,260.21% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NEUP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -126.50% |
Shareholder Yield | n/a |
Earnings Yield | -92.75% |
FCF Yield | -159.19% |
Analyst Forecast
The average price target for NEUP is $21.00, which is 316.67% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.00 |
Price Target Difference | 316.67% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NEUP has an Altman Z-Score of -15.46 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -15.46 |
Piotroski F-Score | 1 |